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Liver homogenates phosphorylated Ins 1,3,4-P, to an InsP, isomer that was distinct from Ins 1,3,4,5-P,. This InsP, isomer 
accumulated invasopressin stimulated hepatocytes prelabeled with myflH]inositol with a time course that lagged behind 
Ins 1,3,4-P, formation. The Ins 1,3,4-P, kinase responsible for its formation was partially purified from rat liver. The 
enzyme had a K, for Ins 1,3,4-P, of 0.29 ,eM, a K, for ATP of 141 PM and was not affected by changes in free Ca2+ 
in the physiological range. The relationship of this new InsP, isomer to the inositol phosphate signaling pathway is 
discussed. 
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1. INTRODUCTION 
As in many other cell types, Ca2+ signaling in 
liver is initiated by an agonist-induced hydrolysis 
of inositol lipids in the plasma membrane to 
inositol phosphates and 1,2-diacylglycerol [ 1,2]. 
The inositol 1,4,5_trisphosphate (Ins 1,4,5-P3) re- 
leased in this process acts as a Ca2+ mobilizing 
second messenger by opening a Ca2+ channel 
located in a specialized intracellular compartment. 
Once formed, Ins 1,4,5-Ps is either dephosphor- 
ylated to Ins 1,4-PZ or phosphorylated to Ins 
1,3,4,5-P4 by a Ca2+/calmodulin-activated 
3-kinase [3-51. Subsequent metabolism of Ins 
1,3,4,5-P4 proceeds via dephosphorylation to Ins 
1,3,4-P3, probably by the same 5-phosphomono- 
esterase that converts Ins 1,4,5-I’s to Ins 1,4-PZ 
[6,7]. The primary pathway of Ins 1,3,4-P3 meta- 
bolism involves dephosphorylation to Ins 3,4-P2 by 
a Li+-sensitive inositol polyphosphate l-phospho- 
monoesterase [8], an enzyme which also dephos- 
phorylates Ins 1,4-I% to Ins 4-P. A minor 
degradative pathway is catalysed by a Li+-insen- 
Correspondence address: J.R. Williamson, University of Penn- 
sylvania School of Medicine, Dept of Biochemistry and 
Biophysics, Philadelphia, PA 19104, USA 
sitive 4-phosphomonoesterase, leading to Ins 
1,3-P2 [9]. Recently, Balla et al. [lO,l l] demon- 
strated that Ins 1,3,4-P3 could be phosphorylated 
to Ins 1,3,4,6-P4 in extracts of adrenal glomerulosa 
cells and that this new InsP4 isomer accumulated in 
intact cells stimulated with angiotensin II. An Ins 
1,3,4-P3 6-kinase activity has also been reported to 
be present in crude liver homogenates [12]. In this 
paper, we demonstrate that this second InsP4 
isomer accumulates in hepatocytes after vaso- 
pressin stimulation and describe a partial purifica- 
tion and characterization of the Ins 1,3,4-P3 kinase 
responsible for its formation. 
2. MATERIALS AND METHODS 
2.1. Measurement of inositol phosphate accumulation in 
hepatocytes 
The procedures used for the isolation of rat hepatocytes, 
labeling of the cells with myo-[‘Hlinositol, and extraction of 
[‘Hlinositol phosphates for HPLC analysis were as described in 
[13]. The HPLC method was modified as follows: a Whatman 
Partisil SAX column was equilibrated at a flow rate of 
1.2 ml/min with 0.55 M NH~HzPO~, pH 4.8. Following sample 
injection, the mobile phase was maintained isocratic for 18 min 
and then increased to 0.83 M NH~HzPO~, pH 4.8, for the next 
15 min. Ins 1,3,4-Ps, Ins 1,4,5-Ps, Ins 1,3,4,5-P4 and the new 
InsP4 isomer eluted at 11, 13, 24 and 27 min, respectively. Frac- 
tions of 0.6 ml were collected and quantified by liquid scintilla- 
tion counting [ 131. 
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2.2. Partial purification of Ins I,3,4-P3 kinase 
Five perfused rat livers were homogenized (1:4, w/v) in 
20 mM Tris-maleate, pH 7.0, 5 mM EGTA, 1 mM 
dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, and 
1 ag/ml each of aprotinin and pepstatin A with ten 10 s bursts 
of a polytron at half maximum speed. The homogenate was 
centrifuged at 1000 x g for 10 min and the supernatant recen- 
trifuged at 85000 x g for 90 min. The 85000 x g supernatant 
was subjected to (NHd)zSOd fractionation and the pellet from 
the 35-55% cut was resuspended in 25 ml of 20 mM Hepes, pH 
7.4, 150 mM KCl, 1 mM MgClz and 1 mM dithiothreitol (col- 
umn buffer). The resuspended pellet was applied to a Sephacryl 
S-300 column (5 cm x 50 cm) equilibrated with the same buffer 
and eluted at a flow rate of 40 ml/h. The fractions containing 
Ins 1,3,4-P3 kinase activity were pooled and applied to a 
DEAE-Sepharose column (1.6 cm x 1.5 cm) equilibrated with 
column buffer. The column was eluted with a 300 ml linear gra- 
dient of 150-600 mM KC1 in column buffer, with Ins 1,3,4-P3 
kinase activity eluting at approx. 450 mM KCl. 
2.3. Ins 1,3,4-P3 kinase assay 
The standard assay buffer for Ins 1,3,4-P3 kinase activity 
consisted of 20 mM Hepes, 110 mM KCl, 10 mM NaCl, 6 mM 
MgClz, 5 mM ATP, 1.0 mM EGTA, 10 mM LiCl, 0.05% 
bovine serum albumin and 7.5 pM [3H]Ins 1,3,4-P3 
(100 dpm/pmol) at pH 7.2. Assays were conducted at 37°C 
initiated by the addition of enzyme and quenched by the addi- 
tion of formic acid (0.1 M final concentration). Product was 
separated from substrate on minicolumns of Dowex AGl-X8 
(0.5 cm x 0.5 cm) and quantified by liquid scintillation coun- 
ting as previously described [13]. To determine the pH 
dependence, 20 mM Mes, 20 mM Mops and 20 mM Hepes were 
substituted for the 20 mM Hepes and the pH adjusted between 
6 and 9. The effect of free Ca*+ on enzyme activity was per- 
formed by adding various amounts of CaClz to the buffer and 
the resulting free Ca2+ concentration determined using a 
Ca’+-sensitive electrode. Protein concentration was determined 
by the method of Bradford [14]. 
2.4. Materials 
Ins 1,4,5-P, was obtained from Behring Diagnostics. [3H]Ins 
1,4,5-P3 was from New England Nuclear. rnyo-[3H]Inositol was 
obtained from American Radiochemicals. Unlabeled and 
tritiated Ins 1,3,4-PS were synthesized from Ins 1,4,5-P3 using 
the purified 3-kinase [15] and Ins 1,3,4,5-P4 5-phosphomono- 
esterase [7]. Dowex AGl-X8 was from Bio-Rad. DEAE- 
Sepharose and Sephacryl S-300 were from Pharmacia. All other 
reagents were from Sigma Chemicals or Fisher Scientific. 
3. RESULTS AND DISCUSSION 
In the presence of ATP, addition of 7.5 PM 
13H]Ins 1,3,4-P3 to a crude liver homogenate 
resulted in the formation of an InsP4, as first 
reported by Shears et al. [12]. Initial examination 
of this InsP4 isomer by HPLC, using a previously 
published elution protocol [13], indicated that it 
comigrated with Ins 1,3,4,5-Pd. However, as the 
pH of the mobile phase was increased from 3.7 to 
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4.8, its retention time increased relative to that for 
Ins 1,3,4,5-P4. Using the modified HPLC elution 
method, two InsP4 isomers were detected in 
vasopressin-stimulated hepatocytes. These cor- 
responded to Ins 1,3,4,5-P4 and the InsP4 pro- 
duced in cell homogenates from Ins 1,3,4-P3. As 
shown in fig.1, Ins 1,4,5-P3 accumulated very 
rapidly following the addition of vasopressin, 
peaking within 30 s. Increases of Ins 1,3,4,5-Pa 
and Ins 1,3,4-P3 were slightly slower, reaching 
their maximum values by 1 min. Increased forma- 
tion of the new InsP4 isomer was detectable within 
30 s, but it accumulated much more slowly than 
the other inositol phosphates and continuously in- 
creased over the 15 min experimental period. This 
time course was consistent with the InsP4 isomer 
originating from Ins 1,3,4-P3. Total accumulation 
of the new InsP4, assessed as cpm above control, 
was small, reaching at best 50% of that of Ins 
1,3,4,5-P4. 
Lithium greatly enhances the agonist-induced 
accumulation of certain inositol phosphates, par- 
ticularly Ins 1,3,4-P3, by inhibiting at least 2 en- 
zymes, inositol monophosphate l-phosphomono- 
esterase [ 171 and inositol polyphosphate 1 -phos- 
phomonoesterase [16]. Fig.2 shows that there was 
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Fig. 1. Time course of inositol phosphate accumulation in myo- 
[‘Hlinositol prelabeled hepatocytes following addition of 
40 nM vasopressin. 10 mg dry wt of cells were quenched by 
addition of perchloric acid (4% final) [13] at the above times 
after vasopressin addition. Each point represents the mean + 
SE of three separate experiments. The assignment of InsP4 as 
Ins 1,3,4,6-P4 is based on the studies of others [I 1,121. 
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Fig.2. Effect of LiCl on the time course of Ins 1,3,4-P3 and Ins 
1,3,4,6-P4 accumulation in myo-[‘Hlinositol prelabeled 
hepatocytes following addition of 40 nM vasopressin. Cells 
were preincubated for 10 min with 10 mM LiCl. 10 mg dry wt 
of cells were quenched by addition of perchloric acid (4% final) 
[13] at the above times after vasopressin addition. Each point 
represents the mean k SE of three separate experiments. The 
assignment of InsP4 as Ins 1,3,4,6-P4 is based on the studies of 
others [11,12]. 
little effect of LiCl on the accumulation of the new 
InsP4 isomer, despite a ten-fold increase in its 
precursor, Ins 1,3,4-P3. Since the partially purified 
Ins 1,3,4-P3 kinase was not affected by LiCl (see 
below), these data suggest hat the concentration 
of Ins 1,3,4-P3 produced in vasopressin-stimulated 
hepatocytes, approx. 2 PM [l], was near saturating 
for the Ins 1,3,4-P3 kinase. 
The Ins 1,3,4-P3 kinase was partially purified us- 
ing the steps summarized in table 1. This procedure 
resulted in a 50-fold increase in its specific activity 
and the elimination of the Li+-insensitive Ins 
1,3,4-P3 4-phosphomonoesterase activity. Remain- 
ing Ins 1,3,4-P3 1-phosphomonoesterase activity 
was prevented by the addition of 10 mM LiCl, 
which had no effect on the Ins 1,3,4-P3 kinase ac- 
tivity. 
The relationship of Ins 1,3,4-P3 concentration to 
the reaction velocity for the Ins 1,3,4-P3 kinase is 
shown in fig.3. From 3 separate preparations of 
enzyme, the K,,, for Ins 1,3,4-P3 was 0.29 f 
0.06 PM (mean + SE) and the K,,, for ATP, in the 
presence of 7.5 ,BM Ins 1,3,4-P3 and 5 mM MgC12, 
was 141 -+ 11 PM. Chelation of Mg2+ by excess 
EDTA completely inhibited InsPA formation, in- 
dicating that MgATP was the actual substrate. The 
enzyme exhibited a broad pH profile, with the 
highest activity expressed between pH 6.6 and 7.5 
(not shown). 
Unlike the Ca2+/calmodulin activated Ins 
1,4,5-P3 3-kinase, Ins 1,3,4-P3 kinase activity was 
not affected by increasing free Ca2+ concentration 
over the physiological range (lo-* to 10e5 M). As 
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Fig.3. Representative double reciprocal plot of the substrate 
velocity relationship of the partially purified Ins 1,3,4-P, 
kinase. Assays were carried out as described in section 2, except 
the concentration of substrate, Ins 1,3,4-P3, was varied. Units 
of velocity were fmol/min per mg protein. 
Table 1 
Partial purification of Ins 1,3,4-P9 kinase from rat liver 
Purification 
step 
Total Total Specific Recovery Purification 
activity protein activity (%) (-fold) 
(pmol/min) (mg) (pmol/min 
per mg) 
85000 X supernatant g 9300 7280 1.3 100 1 
35-55% (NH&S04 fraction 7250 2630 2.8 78 2.2 
Sephacryl S-300 940 56 16.8 10 12.9 
DEAE-Sepharose 322 5 64.4 4 49.5 
55 
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the free Ca2+ concentration was further increased, 
the activity of the enzyme decreased, with a 50% 
inhibition occurring at approx. 500 PM free Ca’+. 
This pattern of inhibition by Ca2+ is similar to that 
observed with the purified platelet [18] and brain 
[7] soluble 5phosphomonoesterases. Further- 
more, as shown in separate experiments, the Ins 
1,3,4-Ps kinase did not bind to a calmodulin affini- 
ty column in the presence of Ca2+, while most of 
the Ins 1,4,5-P3 kinase activity, present in the same 
sample, was retained by the matrix and eluted only 
upon removal of Ca2+ by excess EGTA. 
The new InsP4 isomer formed in this study is 
most likely Ins 1,3,4,6-P4, since it has been shown 
to be the product of Ins 1,3,4-P3 phosphorylation 
in liver [12] and adrenal glomerulosa cell 
homogenates [l I]. The demonstration that its ac- 
cumulation is agonist-sensitive not only in adrenal 
glomerulosa cells [10,19], but also in liver, suggests 
that enhanced formation of Ins 1,3,4,6-P4 is a 
general response to stimulation by Ca’+-mobilizing 
agonists. Cells possess at least two routes for 
dephosphorylation of Ins 1,3,4-P3, both with 
substantially greater capacity than this phosphory- 
lation pathway, making it an unlikely disposal 
route for Ins 1,3,4-P3. Balla et al. [ll] state that 
Ins 1,3,4,6-P4 can be converted to InsPs by adrenal 
glomerulosal cell extracts. Phosphorylation of Ins 
1,3,4-P3 to Ins 1,3,4,6-P4 may thus represent an 
important route for synthesis of higher phospho- 
rylated inositol phosphates. Similarly, it may be in- 
volved in coordinating the functions of the inositol 
phosphates of the Ca2+ -mobilizing signal transduc- 
tion pathway with the functions of the more slowly 
metabolized higher phosphorylated inositol phos- 
phates, which may also have physiological signal- 
ing roles [20]. 
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